My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 115

    1.

    Inorganic arsenic and human prostate cancer.

    Benbrahim-Tallaa L, Waalkes MP.

    Environ Health Perspect. 2008 Feb;116(2):158-64. Review.PMID: 18288312 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Mechanisms of acquired androgen independence during arsenic-induced malignant transformation of human prostate epithelial cells.

    Benbrahim-Tallaa L, Webber MM, Waalkes MP.

    Environ Health Perspect. 2007 Feb;115(2):243-7. Epub 2006 Nov 20.PMID: 17384772 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation.

    Benbrahim-Tallaa L, Webber MM, Waalkes MP.

    Environ Health Perspect. 2005 Sep;113(9):1134-9.PMID: 16140617 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Cadmium and prostate cancer.

    Waalkes MP, Rehm S.

    J Toxicol Environ Health. 1994 Nov;43(3):251-69. Review.PMID: 7966437 [PubMed - indexed for MEDLINE]Related articles

    5.

    Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.

    Clewell HJ, Thomas RS, Gentry PR, Crump KS, Kenyon EM, El-Masri HA, Yager JW.

    Toxicol Appl Pharmacol. 2007 Aug 1;222(3):388-98. Epub 2007 Mar 30.PMID: 17499324 [PubMed - indexed for MEDLINE]Related articles

    6.

    Inorganic arsenite-induced malignant transformation of human prostate epithelial cells.

    Achanzar WE, Brambila EM, Diwan BA, Webber MM, Waalkes MP.

    J Natl Cancer Inst. 2002 Dec 18;94(24):1888-91.PMID: 12488483 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Physiologically based pharmacokinetic modeling of arsenic in the mouse.

    Gentry PR, Covington TR, Mann S, Shipp AM, Yager JW, Clewell HJ 3rd.

    J Toxicol Environ Health A. 2004 Jan 9;67(1):43-71.PMID: 14668111 [PubMed - indexed for MEDLINE]Related articles

    8.

    Endocrine disruptors and prostate cancer risk.

    Prins GS.

    Endocr Relat Cancer. 2008 Sep;15(3):649-56. Epub 2008 Jun 4. Review.PMID: 18524946 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.

    Carruba G.

    J Cell Biochem. 2007 Nov 1;102(4):899-911. Review.PMID: 17786930 [PubMed - indexed for MEDLINE]Related articles

    10.

    Respiratory cancer and inhaled inorganic arsenic in copper smelters workers: a linear relationship with cumulative exposure that increases with concentration.

    Lubin JH, Moore LE, Fraumeni JF Jr, Cantor KP.

    Environ Health Perspect. 2008 Dec;116(12):1661-5. Epub 2008 Jul 23.PMID: 19079717 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Mechanism of arsenic carcinogenesis: an integrated approach.

    Rossman TG.

    Mutat Res. 2003 Dec 10;533(1-2):37-65. Review.PMID: 14643412 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cadmium carcinogenesis in review.

    Waalkes MP.

    J Inorg Biochem. 2000 Apr;79(1-4):241-4. Review.PMID: 10830873 [PubMed - indexed for MEDLINE]Related articles

    13.

    Inorganic arsenic--ambient level approach to the control of occupational cancerigenic exposures.

    Blejer HP, Wagner W.

    Ann N Y Acad Sci. 1976;271:179-86.PMID: 1069501 [PubMed - indexed for MEDLINE]Related articles

    14.

    Appropriate use of animal models in the assessment of risk during prenatal development: an illustration using inorganic arsenic.

    Holson JF, Desesso JM, Jacobson CF, Farr CH.

    Teratology. 2000 Jul;62(1):51-71. Review.PMID: 10861633 [PubMed - indexed for MEDLINE]Related articles

    15.

    Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation.

    Benbrahim-Tallaa L, Waterland RA, Styblo M, Achanzar WE, Webber MM, Waalkes MP.

    Toxicol Appl Pharmacol. 2005 Aug 15;206(3):288-98. Epub 2005 Jan 18.PMID: 16039940 [PubMed - indexed for MEDLINE]Related articles

    16.

    Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.

    Chen H, Liu J, Zhao CQ, Diwan BA, Merrick BA, Waalkes MP.

    Toxicol Appl Pharmacol. 2001 Sep 15;175(3):260-8.PMID: 11559025 [PubMed - indexed for MEDLINE]Related articles

    17.

    Animal models for the study of prostate carcinogenesis.

    Bosland MC.

    J Cell Biochem Suppl. 1992;16H:89-98. Review.PMID: 1289679 [PubMed - indexed for MEDLINE]Related articles

    18.

    The carcinogenicity of arsenic.

    Pershagen G.

    Environ Health Perspect. 1981 Aug;40:93-100. Review.PMID: 7023936 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Carcinogen exposure and epigenetic silencing in bladder cancer.

    Marsit CJ, Karagas MR, Schned A, Kelsey KT.

    Ann N Y Acad Sci. 2006 Sep;1076:810-21.PMID: 17119258 [PubMed - indexed for MEDLINE]Related articles

    20.

    Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice.

    Waalkes MP, Liu J, Ward JM, Diwan BA.

    Toxicol Appl Pharmacol. 2004 Aug 1;198(3):377-84.PMID: 15276417 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity